logo

Last Update

This profile was last updated on 6/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Bob Uger?

Bob Uger

Chief Scientific Officer

Trillium Therapeutics Inc.

HQ Phone:  (416) 595-0627

Direct Phone: (416) ***-**** ext. ***direct phone

Email: b***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Trillium Therapeutics Inc.

96 Skyway Avenue

Toronto, Ontario,M9W 4Y9

Canada

Company Description

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The Company's lead program is a SIRPaFc antibody-like fusion protein that consists of the CD47-binding domain of human SIRPa lin...more

Web References(25 Total References)


Stem Cell Therapeutics - Corporate

www.stemcellthera.com [cached]

Dr. Bob Uger | Chief Scientific Officer
Dr. Bob Uger | Chief Scientific Officer Dr. Uger is responsible for developing and implementing the scientific direction of SCT, and oversees both internal product development and external research discovery programs. He also acts as the company’s scientific liaison with respect to global collaborations with academic and hospital research scientists. Dr. Uger was previously Vice-President, Research & Development at Trillium Therapeutics. He joined Trillium from Aventis Pasteur where he was a Senior Research Scientist involved in cancer vaccine research. He received his Ph.D. in immunology from the University of Toronto.


Targeting Tumor Myeloid Cells | Discovery On Target 2017

www.giiconference.com [cached]

Bob Uger, Ph.D., CSO, Trillium Therapeutics, Inc.
Bob Uger, Ph.D., CSO, Trillium Therapeutics, Inc.


www.sec.gov

Robert Uger
Chief Scientific Officer Dr. Uger is the Chief Scientific Officer of Trillium since April 9, 2013 and was the Vice President, Research of Trillium Therapeutics Inc. (private) since 2003. He joined Trillium from Aventis Pasteur where he was a Senior Research Scientist involved in cancer vaccine research. As Chief Scientific Officer, Dr. Uger is responsible for developing and implementing our scientific direction, and oversees both internal product development and external research and development programs. Dr. Robert Uger - Chief Scientific Officer Dr. Uger became the Chief Scientific Officer on our merger with Trillium Therapeutics Inc. (private) in April 2013. Dr. Uger is responsible for developing and implementing our scientific direction, and overseeing both internal product development and external research discovery programs. He also acts as our scientific liaison with respect to global collaborations with academic and hospital research scientists. Dr. Uger joined Trillium Therapeutics Inc. (private)in 2003 from Aventis Pasteur where he was a Senior Research Scientist involved in cancer vaccine research. He received his Ph.D. in Immunology from the University of Toronto.


Immunomodulatory Approaches

www.immuno-oncologyeurope.com [cached]

Bob Uger, Ph.D., CSO, Trillium Therapeutics, Inc.


www.immuno-oncologyeurope.com

Bob Uger, Ph.D., Chief Scientific Officer, Trillium Therapeutics, Inc.
Dr. Uger is responsible for developing and implementing Trillium's scientific direction, and oversees both internal product development and external research discovery programs. He also acts as the Company's scientific liaison with respect to global collaborations with academic and hospital research scientists. Dr. Uger was previously Vice-President, Research & Development at Trillium Therapeutics (private company). He joined Trillium from Aventis Pasteur where he was a Senior Research Scientist involved in cancer vaccine research. He received his Ph.D. in immunology from the University of Toronto.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory